First Biosimilar Approval Alert: Health Canada Approves Alvotech’s AVT04 commercialised by JAMP as Jamteki™, the First Stelara® (ustekinumab) Biosimilar in Canada
Alvotech and JAMP Pharma announced that Health Canada has granted marketing authorization for Jamteki™ (AVT04), the first approved biosimilar to…
Pearce IP is Australia and New Zealand’s leading life sciences-focused intellectual property law firm.
Supporting life sciences clients from early-stage R&D through to commercial launch and beyond.
pearceIP.law | [email protected] | +61 2 9023 9988 | +64 4 886 1199
Popular articles from this firm
